Evidence map›Paper›PMID 29912188›Full record

ArticleJournal of visualized experiments : JoVE2018

Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines.

Julia B Carleton, Kristofer C Berrett, Jason Gertz

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Julia B CarletonDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah.
Kristofer C BerrettDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah.
Jason GertzDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah; jay.gertz@hci.utah.edu.

Funding

TRAINING PROGRAM IN GENETICST32GM007464 · NIGMS · UNIVERSITY OF UTAH · PI GRUNWALD, DAVID J., STANFIELD, GILLIAN · 1985 to 2020
$6.1M
In situ evaluation of combinatorial gene regulation in the human genomeR01HG008974 · NHGRI · UNIVERSITY OF UTAH · PI GERTZ, JASON · 2017 to 2021
$3.2M
Impact of enhancer sequence and interacting factors on estrogen receptor-mediatedR00HG006922 · NHGRI · UNIVERSITY OF UTAH · PI GERTZ, JASON · 2014 to 2016
$811k
NHGRI NIH HHS R00 HG006922NHGRI NIH HHS R01 HG008974NIGMS NIH HHS T32 GM007464
6 · The paper itself

Abstract

Multiple enhancers often regulate a given gene, yet for most genes, it remains unclear which enhancers are necessary for gene expression, and how these enhancers combine to produce a transcriptional response. As millions of enhancers have been identified, high-throughput tools are needed to determine enhancer function on a genome-wide scale. Current methods for studying enhancer function include making genetic deletions using nuclease-proficient Cas9, but it is difficult to study the combinatorial effects of multiple enhancers using this technique, as multiple successive clonal cell lines must be generated. Here, we present Enhancer-i, a CRISPR interference-based method that allows for functional interrogation of multiple enhancers simultaneously at their endogenous loci. Enhancer-i makes use of two repressive domains fused to nuclease-deficient Cas9, SID and KRAB, to achieve enhancer deactivation via histone deacetylation at targeted loci. This protocol utilizes transient transfection of guide RNAs to enable transient inactivation of targeted regions and is particularly effective at blocking inducible transcriptional responses to stimuli in tissue culture settings. Enhancer-i is highly specific both in its genomic targeting and its effects on global gene expression. Results obtained from this protocol help to understand whether an enhancer is contributing to gene expression, the magnitude of the contribution, and how the contribution is affected by other nearby enhancers.

Indexed as

AnimalsCell LineCRISPR-Cas SystemsEnhancer Elements, GeneticHumans

Identifiers

PMID29912188
PMCPMC6101477

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.